Back to EXEL

Krensavage Asset Management, LLC → EXEL

Krensavage Asset Management, LLC EXEL Position History

Exelixis, Inc. • Healthcare

Quarters held
4
Latest value
$17.5M
Q3 2026
Peak value
$21.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$21.6M
Q1 2026$17.8M
Q2 2026$20.2M
Q3 2026$17.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$17.5M299.4K——
Q2 2026$20.2M370.7K——
Q1 2026$17.8M415.7K——
Q4 2025$21.6M493.5K——

Other funds holding EXEL

Other Krensavage Asset Management, LLC positions

UTHR

UNITED THERAPEUTICS CORP

$50M
UTHR

UNITED THERAPEUTICS CORP

$44.5M
ENTA

ENANTA PHARMACEUTICALS INC

$43.6M
ENTA

ENANTA PHARMACEUTICALS INC

$41.8M
JAZZ

JAZZ PHARMACEUTICALS PLC

$40.4M
JAZZ

JAZZ PHARMACEUTICALS PLC

$38.9M
ENTA

ENANTA PHARMACEUTICALS INC

$37.8M
UTHR

UNITED THERAPEUTICS CORP

$37.5M